Keyphrases
Glioblastoma
100%
Tumor
76%
Myeloid-derived Suppressor Cells
74%
Interleukin-15 (IL-15)
62%
Dual Targeting
62%
Rare Variants
62%
Nanoparticles
62%
Illustrative Case
62%
Brain Tumor
62%
Glioneuronal Tumor
62%
Targeted Agents
62%
Tumor Cells
62%
Pediatric
62%
NTRK3 Fusion
62%
Chimeric Antigen Receptor T Cells (CAR-T)
62%
PEGylated Lipid Nanoparticles
62%
MYO5A
62%
Liposomes
62%
Glioma Model
39%
T Cells
35%
Tumor Microenvironment
35%
Central Nervous System Tumors
26%
Syngeneic
26%
Liposomal
25%
DNA Methylation Profiling
17%
B Cells
17%
Targeting Moieties
17%
Methylation Class
17%
World Health Organization Classification
17%
Cargo Delivery
12%
Blood-brain Tumor Barrier
12%
Microglia
12%
High Efficiency
12%
Systemic Injection
12%
Organoids
12%
Extravascular
12%
Invasive Tumors
12%
Pegylated Liposomal Doxorubicin
12%
Blood-tumor Barrier
12%
Regulatory T Cells
12%
Tumor-associated
12%
Nanosized Particles
12%
Lipids
12%
Non-immune
12%
Tumor Margin
12%
Glioblastoma Spheroid
12%
Suppressor Macrophages
12%
Fluorescent Dextran
12%
Tumor Brain
12%
Precise Classification
8%
Medicine and Dentistry
Neoplasm
80%
Chimeric Antigen Receptor T-Cell
62%
Glioblastoma
62%
Myeloid-Derived Suppressor Cell
62%
Pediatrics
62%
Tumor Cell
62%
MYO5A
62%
T Cell
44%
Tumor Microenvironment
44%
Tumor of Central Nervous System
18%
Ganglioglioma
17%
In Vitro
17%
Immunosuppressive Drug
17%
DNA Methylation
12%
Methylation
12%
Phosphotransferase
12%
Immunocompetent Cell
8%
B Cell
8%
Cytotoxic T-Cell
8%
Natural Killer Cell
8%
Secretion (Process)
8%
RNA Sequencing
8%
Dendritic Cell
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Flow Cytometry
8%
Clinical Study
8%
Larotrectinib
6%
Targeted Therapy
6%
Midline Shift
6%
Central Nervous System Tumor
6%
Genomic DNA
6%
Magnetic Resonance Imaging of the Brain
6%
Speech Delay
6%
Surgery
6%
Developmental Milestone
6%
Gene Targeting
6%
Immunology and Microbiology
Chimeric Antigen Receptor T-Cell
62%
Myeloid-Derived Suppressor Cell
62%
Tumor Cell
62%
T Cell
52%
Syngenic
31%
Immunosuppressive Drug
20%
B Cell
20%
Dendritic Cell
10%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Transgenics
10%
Natural Killer Cell
10%
Immunocompetent Cell
10%
RNA Sequencing
10%
Cytotoxic T-Cell
10%
Secretion (Process)
10%
Murine
10%
Myeloid
10%